Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas

Study Purpose

Vestibular schwannomas (VS) arise from the vestibulocochlear (hearing and balance) nerve, located at the base of the brain. Although benign, VS can enlarge over time, resulting in debilitating symptoms; therefore, surgical removal is frequently offered. One significant risk of surgery is inadvertent injury to the facial nerve, which lies adjacent to the vestibulocochlear nerve. Currently, the nerve's course is only revealed during surgical dissection and injury can cause permanent facial weakness. It would therefore be useful for the surgeon to know the course of the nerve before operating. To this end, a new MRI technique known as probabilistic diffusion tensor tractography (DTT) has shown potential in revealing the course of the facial nerve pre-operatively. However, its clinical reliability remains uncertain. This study aims to investigate the reliability of DTT in identifying the course of the facial nerve preoperatively in patients undergoing surgery for VS. The future benefit would be to enable surgeons to operate with more confidence and potentially reduce the chance of nerve injury. The study will recruit adult patients due to have surgery for VS. The only change to the participants' clinical pathways will be the addition of a DTT sequence to their pre-operative MRI scans (increasing scanning time by approximately 10 minutes).

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - The capacity to understand the patient information sheet and the ability to provide written informed consent.
  • - >1.5cm extrameatal tumor determined to represent a vestibular schwannoma by preoperative imaging.
  • - HB grade I or II preoperatively.

Exclusion Criteria:

  • - Patients not meeting the above inclusion criteria.
  • - Standard contraindications to MRI.
- Previous cranial radiotherapy or previous surgery to the cerebellopontine angle cistern or IAM

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04057976
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

King's College Hospital NHS Trust
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Steve Connor, MBBS, FRCR
Principal Investigator Affiliation King's College Hospital NHS Trust
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries United Kingdom
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Vestibular Schwannoma
Additional Details

BACKGROUND AND RATIONALE Vestibular schwannomas (VS) are peripheral nerve sheath tumours arising from the vestibulocochlear nerve, which emerges from the brainstem at the base of the brain and enters the structures of the inner ear via a small bony canal within the skull (internal auditory meatus). VS account for 8% (Johnson J et al.) of intracranial tumours and, although benign, these tumours can grow resulting in several potentially debilitating symptoms, including hearing loss, vertigo, tinnitus, facial paralysis and meningitis. Furthermore, large tumours may cause compression on the brainstem, which can, in some cases, have life-threatening consequences (Johnson J et al.). Therefore, patients diagnosed with larger tumours (>1.5cm extrameatal component) are frequently offered surgical resection (as opposed to conservative management or stereotactic radiosurgery). As surgical techniques have improved, the goal of surgery has broadened to include not only tumour removal, but also preservation of the function of the nerves involved by VS. In particular, surgical resection aims to preserve the function of the facial nerve, responsible for innervating the muscles of facial expression, and which runs alongside the vestibulocochlear nerve and is frequently displaced and flattened by VS. Given its juxtaposition, the facial nerve is at high risk of injury during surgery. Injury to the facial nerve (and consequent debilitating facial weakness or paralysis) is a serious potential risk of vestibular schwannoma (VS) surgery. However, at present, the only means of avoiding nerve injury involves a combination of meticulous surgical technique and the use of a facial nerve monitor (a device that can detect activity within the facial muscles when stimulated by a surgeon-held probe); however, despite this, facial nerve injury may still occur. Indeed, until the surgeon begins operating, the course of the facial nerve is unknown. In a large series (>1000 surgical cases) by Sampath et al., the position of the facial nerve position was found most commonly on the anterior middle portion of the tumour; however, in a smaller proportion of cases, the nerve lay in 1 of 7 additional locations (Sampath et al.). Therefore, it follows that preoperative detection and identification of the course of the facial nerve would be extremely useful to guide surgery and reduce the potential risk of neuronal injury. There now exists a potential means of non-invasively identifying the course of the facial nerve using advanced applications of magnetic resonance imaging (MRI). This involves utilising a technique known as diffusion tensor tractography (DTT), which has the capacity to detect the direction (vector) of diffusivity in a particular volume of tissue (voxel) (Mukherjee et al.). This data can be subsequently used to reveal structures, such as nerve fibre tracts, that are arranged along particular vectors, enabling them to be differentiated from surrounding tissue (Cauley et al.). This cannot be achieved using standard MRI sequences, in which the flattened nerve often becomes indistinguishable from the adjacent VS. Fortunately, as MRI represents the current means of diagnosing and characterising VS, adding an additional DTT sequence to a patient's scan does not represent a significant burden (only approximately 10 additional minutes of scanning time to acquire the DTT data). Several groups (Choi et al., Taoka et al., Gerganov et al., Zhang et al. and Song et al.) have used DTT to delineate the course of the facial nerve in patients with VS and the majority have reported high success rates (>90% agreement with operative findings). However, many of these studies employed 'deterministic' DTT, which has drawbacks that limit its reliability in the setting of small fibre tracts with complex geometry. In particular, it is unable to accurately track fibres that cross, split or merge because the technique assumes that adjacent voxels have similar vectors. In order to overcome these limitations, we propose using the newer 'probabilistic' DTT technique that calculates a vector for each voxel analysed. It therefore has the capacity to account for complex geometries, such as those encountered in the facial nerve, particularly where its course is heavily distorted by tumour tissue. Zolal et al. used this technique in 21 patients with VS, resulting in an agreement rate of 81% for the position of the facial nerve and 33% for the cochlear nerve (Zolal et al.). However, there is an ongoing need for further studies in this area. This project seeks to clarify the accuracy, reproducibility and practicality of probabilistic DTT in locating the facial nerve pre-operatively. If the technique proves accurate, it will potentially help with pre-operative planning and avoidance of facial nerve injury during VS surgery. Additionally the project seeks to clarify associated practical issues; in particular, the inter-observer/intra-observer variability (i.e. whether the reading radiologists agree with each other and themselves when analysing DTT images), whether the facial nerve position can be partially inferred on conventional sequences (comparing this with DTT) and whether adjacent nerves (such as the vestibulocochlear nerve) can be identified, which may further help with surgical preoperative planning. HYPOTHESIS: It is hypothesised that preoperative advanced probabilistic diffusion tensor tractography (DTT) will accurately demonstrate the position of the facial nerve relative to extrameatal portion of a vestibular schwannoma. It is proposed that the accuracy will be superior to previous studies in which deterministic DTT has been used to demonstrate the position of the facial nerve. This pre-operative mapping has the potential to decrease the rates of facial nerve injury during vestibular schwannoma surgery and allow for increased resection of the tumour. STUDY DESIGN: Prospective cohort observational study. For study eligibility and outcome measures, please see the relevant sections. IMAGE ANALYSIS. MRI In addition to standard imaging assessment, further image analysis will be performed offline using MRTrix 3.0 (www.mrtrix.org) in tensor probabililty mode. The presence of one or more cranial nerve tracts will be determined by their consistent depiction following their systematic interrogation with varying anisotropy thresholds. There will be a qualitative assessment of cranial nerve position will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into segments.The assessment will be performed by two observers. Reference standard: The position of the facial nerve with respect to the extrameatal portion of the vestibular schwannoma will be assessed at surgery will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into multiple segments in the same manner as above. This assessment will be made independently of the results of the pre-operative probabilistic DTT (the neurosurgeon recording the data will be blinded to the DTT findings). STATISTICAL CONSIDERATIONS. Sample size calculation: Power calculation based upon a sample size of 32, assuming a true kappa coefficient of 0.9; the 95% confidence interval will have a width of 0.26 (0.77

  • - 1.03).
The number (32) also reflects the number of cases that we expect to recruit over a 2-3 year period.

Arms & Interventions

Arms

Experimental: Patients having pre-operative DTT prior to surgery

All patients in this study will undergo DTT as part of a pre-operative MRI.

Interventions

Diagnostic Test: - Probabilistic diffusion tensor tractography

Patients enrolled in this study will undergo probabilistic diffusion tensor tractography (additional MRI sequence) preoperatively in order to determine whether this it is possible to determine the course of the facial nerve.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

London, United Kingdom

Status

Recruiting

Address

King's College Hospital NHS Foundation Trust

London, , SE5 9RS

Site Contact

Kirsty Hedditch

[email protected]

02032993841

Stay Informed & Connected